Atlas Trials

Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy

Clinical trial NCT01469156 · COMPLETED

Trial details

NCT number
NCT01469156
Sponsor
Southeast Retina Center, Georgia
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Polypoidal Choroidal Vasculopathy
Start date
2011-09-01
Primary completion
2015-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.